A Trial to Investigate Recovery From COVID-19 With C21 in Adult Subjects
Study sponsor: Vicore Pharma AB
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2022-04-25Actual
Enrollment · participants272Actual
Source updated2023-12-14Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.